Literature DB >> 33345445

Cancer-secreted miRNAs regulate amino-acid-induced mTORC1 signaling and fibroblast protein synthesis.

Miranda Y Fong1,2, Wei Yan1, Majid Ghassemian3, Xiwei Wu4, Xin Zhou5, Minghui Cao1, Li Jiang1, Jessica Wang1, Xuxiang Liu2, Jin Zhang5, Shizhen Emily Wang1.   

Abstract

Metabolic reprogramming of non-cancer cells residing in a tumor microenvironment, as a result of the adaptations to cancer-derived metabolic and non-metabolic factors, is an emerging aspect of cancer-host interaction. We show that in normal and cancer-associated fibroblasts, breast cancer-secreted extracellular vesicles suppress mTOR signaling upon amino acid stimulation to globally reduce mRNA translation. This is through delivery of cancer-derived miR-105 and miR-204, which target RAGC, a component of Rag GTPases that regulate mTORC1 signaling. Following amino acid starvation and subsequent re-feeding, 13 C-arginine labeling of de novo synthesized proteins shows selective translation of proteins that cluster to specific cellular functional pathways. The repertoire of these newly synthesized proteins is altered in fibroblasts treated with cancer-derived extracellular vesicles, in addition to the overall suppressed protein synthesis. In human breast tumors, RAGC protein levels are inversely correlated with miR-105 in the stroma. Our results suggest that through educating fibroblasts to reduce and re-prioritize mRNA translation, cancer cells rewire the metabolic fluxes of amino acid pool and dynamically regulate stroma-produced proteins during periodic nutrient fluctuations.
© 2020 The Authors.

Entities:  

Keywords:  breast cancer; extracellular vesicles; mRNA translation; mTORC1; microRNA

Mesh:

Substances:

Year:  2020        PMID: 33345445      PMCID: PMC7857427          DOI: 10.15252/embr.202051239

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  40 in total

1.  The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1.

Authors:  Yasemin Sancak; Timothy R Peterson; Yoav D Shaul; Robert A Lindquist; Carson C Thoreen; Liron Bar-Peled; David M Sabatini
Journal:  Science       Date:  2008-05-22       Impact factor: 47.728

Review 2.  The role of the complement system in cancer.

Authors:  Vahid Afshar-Kharghan
Journal:  J Clin Invest       Date:  2017-03-01       Impact factor: 14.808

3.  Proteome profiling of exosomes derived from human primary and metastatic colorectal cancer cells reveal differential expression of key metastatic factors and signal transduction components.

Authors:  Hong Ji; David W Greening; Thomas W Barnes; Justin W Lim; Bow J Tauro; Alin Rai; Rong Xu; Christopher Adda; Suresh Mathivanan; Wei Zhao; Yanhong Xue; Tao Xu; Hong-Jian Zhu; Richard J Simpson
Journal:  Proteomics       Date:  2013-05       Impact factor: 3.984

Review 4.  mTOR Signaling in Growth, Metabolism, and Disease.

Authors:  Robert A Saxton; David M Sabatini
Journal:  Cell       Date:  2017-03-09       Impact factor: 41.582

Review 5.  The Emerging Hallmarks of Cancer Metabolism.

Authors:  Natalya N Pavlova; Craig B Thompson
Journal:  Cell Metab       Date:  2016-01-12       Impact factor: 27.287

6.  The PRIDE database and related tools and resources in 2019: improving support for quantification data.

Authors:  Yasset Perez-Riverol; Attila Csordas; Jingwen Bai; Manuel Bernal-Llinares; Suresh Hewapathirana; Deepti J Kundu; Avinash Inuganti; Johannes Griss; Gerhard Mayer; Martin Eisenacher; Enrique Pérez; Julian Uszkoreit; Julianus Pfeuffer; Timo Sachsenberg; Sule Yilmaz; Shivani Tiwary; Jürgen Cox; Enrique Audain; Mathias Walzer; Andrew F Jarnuczak; Tobias Ternent; Alvis Brazma; Juan Antonio Vizcaíno
Journal:  Nucleic Acids Res       Date:  2019-01-08       Impact factor: 16.971

7.  MOAP-1-mediated dissociation of p62/SQSTM1 bodies releases Keap1 and suppresses Nrf2 signaling.

Authors:  Chong Teik Tan; Hao-Chun Chang; Qiling Zhou; Chundong Yu; Nai Yang Fu; Kanaga Sabapathy; Victor C Yu
Journal:  EMBO Rep       Date:  2021-01-04       Impact factor: 9.071

8.  A microRNA network regulates proliferative timing and extracellular matrix synthesis during cellular quiescence in fibroblasts.

Authors:  Eric J Suh; Matthew Y Remillard; Aster Legesse-Miller; Elizabeth L Johnson; Johanna M S Lemons; Talia R Chapman; Joshua J Forman; Mina Kojima; Eric S Silberman; Hilary A Coller
Journal:  Genome Biol       Date:  2012-12-22       Impact factor: 13.583

9.  Broad role for YBX1 in defining the small noncoding RNA composition of exosomes.

Authors:  Matthew J Shurtleff; Jun Yao; Yidan Qin; Ryan M Nottingham; Morayma M Temoche-Diaz; Randy Schekman; Alan M Lambowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-10       Impact factor: 11.205

10.  The functional synergism of microRNA clustering provides therapeutically relevant epigenetic interference in glioblastoma.

Authors:  Vivek Bhaskaran; Michal O Nowicki; Mahmoud Idriss; Miguel A Jimenez; Gianmarco Lugli; Josie L Hayes; Ahmad Bakur Mahmoud; Rachel E Zane; Carmela Passaro; Keith L Ligon; Daphne Haas-Kogan; Agnieszka Bronisz; Jakub Godlewski; Sean E Lawler; E Antonio Chiocca; Pierpaolo Peruzzi
Journal:  Nat Commun       Date:  2019-01-25       Impact factor: 14.919

View more
  3 in total

1.  Emerging roles and mechanisms of microRNA‑222‑3p in human cancer (Review).

Authors:  Danhua Wang; Yiwen Sang; Tao Sun; Piaoping Kong; Lingyu Zhang; Yibei Dai; Ying Cao; Zhihua Tao; Weiwei Liu
Journal:  Int J Oncol       Date:  2021-03-24       Impact factor: 5.650

Review 2.  New Immunometabolic Strategy Based on Cell Type-Specific Metabolic Reprogramming in the Tumor Immune Microenvironment.

Authors:  Ji-Yong Sung; Jae-Ho Cheong
Journal:  Cells       Date:  2022-02-22       Impact factor: 6.600

3.  miR-105-5p regulates PD-L1 expression and tumor immunogenicity in gastric cancer.

Authors:  Christos Miliotis; Frank J Slack
Journal:  Cancer Lett       Date:  2021-06-23       Impact factor: 9.756

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.